Partd Final Rule News Today

Centers for Medicare and Medicaid Services CMS finalized a number of regulatory changes relating to how Medicare Advantage MA plans offer supplemental benefits.

Learn about the new Medicare rule allowing biosimilar substitution and its potential impact on patient cost sharing, according to ASHP.

Senate HELP Committee Holds Field Hearing on Private Equity. In the hearing, held at the Massachusetts State House, members discussed the impact of private equity ownership on patients,...

Regulations and rule changes provided a learning experience for brokers in 2023 that can help the industry succeed in 2024 and beyond.

On November 6, 2023, the Centers for Medicare and Medicaid Services ("CMS") released the contract year 2025 proposed rule for Medicare Advantage...

On November 6, 2023, the Centers for Medicare and Medicaid Services (“CMS”) released the contract year 2025 proposed rule for Medicare Advantage (“MA”) organizations and Part D sponsors...

The Medicare Annual Election Period (AEP) is well underway and lasts until Dec. 7.

There are three pillars that health plans should consider in their efforts to improve the member experience and impact disparities in health equity.

Webinar The Centers for Medicare and Medicaid (CMS) Final Rule. the future of Medicare Advantage (MA or Part C), Medicare Cost Plan, the Medicare Prescription Drug Benefit programs, and Programs of All-Inclusive Care for the Elderly (PACE).

Changes to the Medicare Advantage and Part D programs marketing rules at 42 C.F.R. parts 422 and 423, which are applicable for all contract year 2024 marketing and communications beginning September 30, 2023. CMS audited hundreds of marketing and enrollment calls and complaints.